Keyphrases
Multiple Sclerosis
100%
Migraine
76%
Headache
56%
Denmark
49%
Alzheimer's Disease
46%
Spinal Cord Injury
44%
Placebo
34%
Confidence Interval
33%
Dementia
32%
Cerebrospinal Fluid
30%
Healthy Controls
30%
Traumatic Brain Injury
30%
Calcitonin Gene-related Peptide
27%
Randomized Controlled Trial
24%
Migraine without Aura (MWoA)
23%
Cerebral Blood Flow
23%
Meta-analysis
23%
Positron Emission Tomography
21%
Magnetic Resonance Imaging
20%
Relapsing-remitting multiple Sclerosis
19%
Multiple Sclerosis Treatment
18%
Migraine Attack
18%
Cluster Headache
18%
Healthy Volunteers
18%
Intracranial Pressure
17%
Risk Factors
17%
Europe
17%
Randomized Clinical Trial
16%
Quality of Life
16%
Systematic Meta-analysis
16%
Odds Ratio
15%
Narcolepsy
15%
Functional Magnetic Resonance Imaging
15%
Disability
14%
Migraine Treatment
14%
Epilepsy
14%
Subarachnoid Hemorrhage
14%
National Cohort Study
13%
Cognitive Impairment
13%
Intensive Care Unit
13%
Healthy Individuals
13%
Tension-type Headache
13%
Placebo-controlled
13%
Ischemic Stroke
12%
Comorbidity
12%
Parkinson's Disease
12%
Clinical Trials
12%
Frontotemporal Dementia
12%
Idiopathic Rapid Eye Movement Sleep Behavior Disorder (iRBD)
12%
Major Depressive Disorder
12%
Bipolar Disorder
12%
Receptor Binding
12%
Serotonin 2A Receptor (5-HT2AR)
11%
Copenhagen
11%
Severe Traumatic Brain Injury (sTBI)
11%
Mild Cognitive Impairment
11%
Medication Overuse Headache
11%
Pathophysiology
11%
Neurodegenerative Diseases
11%
COVID-19
11%
Idiopathic Intracranial Hypertension
10%
Disease-modifying Therapy
10%
Progressive multiple Sclerosis
10%
Polysomnography
10%
Single-photon Emission Computed Tomography (SPECT)
10%
Neurotrauma
10%
McArdle Disease
10%
Clinical Practice
10%
Huntington's Disease
10%
Migraine Patients
10%
Hazard Ratio
10%
Randomized Placebo-controlled Trial
10%
Clinical Outcomes
10%
Cognitive Function
10%
Chronic Migraine
10%
Randomized Trial
9%
Adverse Events
9%
Genome-wide Association Study
9%
Optic Neuritis
9%
Electroencephalography
9%
Effectiveness Research
9%
Memory Clinic
9%
Hippocampus
9%
5-HT2A Receptor
9%
Diagnostic Criteria
9%
Non-associated
9%
Meningioma
9%
Radioligand
8%
High Risk
8%
Regional Cerebral Blood Flow (rCBF)
8%
Older Adults
8%
Sumatriptan
8%
Disease Activity
8%
Population-based Study
8%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
8%
Randomized Double-blind
8%
Dementia Diagnosis
8%
Serotonin Transporter
8%
Functional Outcome
8%
Preventive Treatment
8%
Medicine and Dentistry
Migraine
57%
Headache
45%
Disease
43%
Multiple Sclerosis
42%
Symptom
35%
Apoplexy
34%
Systematic Review
34%
Magnetic Resonance Imaging
33%
Spinal Cord Injury
32%
Diagnosis
28%
Traumatic Brain Injury
26%
Placebo
25%
Cohort Analysis
23%
Injury
18%
Biological Marker
18%
Prevalence
16%
Meta-Analysis
16%
Randomized Controlled Trial
16%
Alzheimer's Disease
16%
Brain Blood Flow
15%
Rehabilitation Engineering
14%
Quality of Life
14%
Drug Therapy
14%
Brain Ischemia
14%
Intensive Care Unit
13%
Neoplasm
13%
Calcitonin Gene Related Peptide
12%
Cerebrospinal Fluid
12%
Randomized Clinical Trial
12%
Clinical Trial
11%
Brain Injury
10%
Adverse Event
10%
Intracranial Pressure
10%
Observational Study
10%
Tension Headache
10%
Positron Emission Tomography
9%
Cluster Headache
9%
Surgery
9%
Pediatrics
9%
COVID-19
9%
Glycogen Storage Disease Type V
9%
Cerebral Hemorrhage
9%
Pathophysiology
9%
Odds Ratio
8%
Epileptic Seizure
8%
Myopathy
8%
Volunteer
8%
Infusion
8%
Subarachnoid Hemorrhage
8%
Opiate
8%
Artery
8%
Infection
8%
Ganglioglioma
7%
Health Care Cost
7%
Case-Control Study
7%
Neurologic Disease
7%
Idiopathic Intracranial Hypertension
7%
Nervous System Injury
7%
Malignant Neoplasm
7%
Migraine with Aura
7%
Medication Overuse Headache
7%
Atrial Fibrillation
7%
Glioblastoma
7%
Meningioma
7%
Global Disease Burden
6%
Computer Assisted Tomography
6%
Hazard Ratio
6%
Clinician
6%
Auras
6%
Blood Pressure
6%
Health Care
6%
Muscle Strength
6%
Prophylaxis
6%
Cross Sectional Study
6%
Exercise
6%
Anodyne
6%
Trigeminal Neuralgia
5%
Heart Arrest
5%
Neurology
5%
Transformed Migraine
5%
Cohort Effect
5%
Brain Tumor
5%
Analgesia
5%
Hypoxia
5%
Cognition
5%
Acquired Brain Injury
5%
Headache and Facial Pain
5%
Skeletal Muscle
5%
Prospective Study
5%
Hydrocephalus
5%
Receptor
5%
Obstructive Sleep Apnea
5%
Erenumab
5%
Migraine without Aura
5%
Disorders of Consciousness
5%
Functional Magnetic Resonance Imaging
5%